This research, published in preprint on arXiv, shows how fault-tolerant quantum computers and quantum simulation algorithms can model key physical properties of photodetectors; Properties that are expensive and time-consuming to study with classical methods.
By simulating properties such as light absorption and intersystem transition rates for several complex molecules, this framework demonstrates that quantum computing can significantly increase the accuracy and efficiency of optical sensitizer design and reduce dependence on costly laboratory syntheses.
🧪This research provides a practical roadmap for a workflow based on quantum computing in drug discovery and includes estimating the required quantum computing resources and potential advantages in terms of speed and efficiency compared to classical simulations.
Although this work is still at a basic stage, it is an important step towards the practical application of quantum computing in drug development and cancer treatment research, and plans are underway to extend this framework to more complex molecules.
Along with this scientific achievement, Xanadu has announced that it has entered into a business combination with Crane Harbor Acquisition Corp. The new company named Xanadu Quantum Technologies Limited is expected to attract about 500 million US dollars in capital and its shares will be offered on both Nasdaq and Toronto Stock Exchange; An action that can strengthen the growth of this company in the field of photonic-quantum-computing and applied quantum research.
Link to the source